Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion type Assertion NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_head.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion description "[Multivariate analysis showed that the MDM2 polymorphism T309G was associated with an increased risk of developing osteosarcomas [GG versus TT; odds ratio, 2.09; 95% confidence interval (95% CI), 1.15-3.78].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_provenance.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion evidence source_evidence_literature NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_provenance.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion SIO_000772 19451596 NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_provenance.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion wasDerivedFrom befree-20140225 NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_provenance.
- NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_assertion wasGeneratedBy ECO_0000203 NP261795.RAjxOiSQIR--TB7XUaiUgYOkAHJeGHiKL4Vz63szfpbMk130_provenance.